Sort
17,828 grants matching “crispr”
Genome engineering tools for functional screening of non-coding elements
$242,325Neville Sanjana · New York Genome Center · R00 · FY2018 · HG
Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer
$242,263Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2024 · CA
A CRISPR-based modular transgenic system to advance in vivo investigations of angiogenesis and fibrosis
$242,250Matthew J Wolf · University Of Virginia · R21 · FY2022 · OD
Identifying the mechanism of bacteriophage detection by cyclic-oligonucleotide signaling systems
$242,250Joseph Bondy-Denomy · University Of California, San Francisco · R21 · FY2022 · AI
Biochemical mechanisms of Hedgehog signal transduction through primary cilia
$242,250David R Raleigh · University Of California, San Francisco · R21 · FY2023 · HD
Establish a zebrafish genetic mosaic system for disease modeling and developmental biology
$242,250Hui Zong · University Of Virginia · R21 · FY2019 · OD
Deciphering a novel lipid-based mechanism of innate immune modulation
$242,250Suzanne M Noble · University Of California, San Francisco · R21 · FY2023 · AI
Reconstructing the Global Epistasis Network for Aging
$242,250Hao Li · University Of California, San Francisco · R21 · FY2021 · AG
Illuminating gene therapy
$242,250Michael T McManus · University Of California, San Francisco · R21 · FY2024 · OD
Split-GFP tagging and live imaging of hair cell proteins
$242,250Jung-Bum Shin · University Of Virginia · R21 · FY2022 · DC
Comprehensive Characterization of Adaptive Regulatory Variation Linked to Human Disease
$242,227Steven K. Reilly · Yale University · R00 · FY2023 · HG
Development of a Fragile X Syndrome model in the gerbil to study auditory dysfunction
$242,176Yuan Wang · Florida State University · R21 · FY2020 · DC
Defining PRC1.1 as a gatekeeper of lineage plasticity and response to anti-GD2 therapy
$242,168Nathaniel Mabe · Purdue University · R00 · FY2025 · CA
Nucleic Acid-Based Anti-CRISPR Inhibitors of Cas9
$241,926Keith Thomas Gagnon · Wake Forest University Health Sciences · R01 · FY2023 · GM
Immune Evasion through HLA-E in Diffuse Large B-Cell Lymphoma: Defining Its Regulation and Cellular Interactions
$241,884Cynthia Hahn · Dana-Farber Cancer Inst · K08 · FY2025 · CA
Selectable non-mosaic embryo editing
$241,696Hiromitsu Nakauchi · Stanford University · R21 · FY2021 · OD
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
$241,634Sydney X Lu · Stanford University · K08 · FY2023 · CA
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
$241,634Sydney X Lu · Stanford University · K08 · FY2024 · CA
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
$241,634Sydney X Lu · Sloan-Kettering Inst Can Research · K08 · FY2021 · CA
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
$241,634Sydney X Lu · Sloan-Kettering Inst Can Research · K08 · FY2020 · CA
Dissecting the Roles and Requirements for RBM39 in Acute Myeloid Leukemia and Normal Hematopoiesis
$241,634Sydney X Lu · Stanford University · K08 · FY2022 · CA
A novel blood-CSF adaptive immune response in Alzheimer's disease
$241,531David Gate · Northwestern University At Chicago · R00 · FY2024 · NS
Epigenomic regulation of oxidative stress-producing innate immunity in neuroinflammation
$241,530Andrew S Mendiola · University Of California, San Diego · R00 · FY2024 · NS
Bridging the gap between transcriptional activation and cell fate specification in the Drosophila visual system
$241,529Michael William Perry · University Of California, San Diego · R00 · FY2021 · EY
Use of Human Stem Cell-derived RGCs to Study the Mechanism of Optineurin-associated Glaucoma
$241,528Arupratan Das · Indiana University Indianapolis · R00 · FY2021 · EY